Bioven Mono (Human Normal Immunoglobulin)
Bioven Mono (Human Normal Immunoglobulin)
Quality, purity, and safety of BIOVEN MONO correspond with the European Pharmacopoeia regulations for the finished product and raw materials Using the method of ion-exchange chromatographic purification relates these medicines to the last (4th) generation of IVIG, due to BIOVEN MONO have a high safety profile Contains more than 99% of structurally and functionally complete molecules of monomeric IgG 2 validated stages of virus inactivation, including solvent-detergent (SD) treatment. SD is the gold standard of virus inactivation Donors were examined for the absence of antigen and antibodies to HIV 1,2, HCV; plasma pools were tested by IFA for the absence of HBsAg, antigen, and antibodies to HIV 1,2, antibodies to HBV and PCR method for the HCV, HBV NA. Parvovirus B-19 and HIV 1,2 Ready to use Officially approved for use in newborns, pregnant women Indications: cytopenia of various genesis; thrombocytopenic purpura (TP); severe forms of bacterial - toxic and viral infections; polyneuropathy; primary and secondary immunodeficiencies; autoimmune diseases.
50%(50mg/mL) Solution for Infusion (IV)